Correction: HDAC7 is an actionable driver of therapeutic antibody resistance by macrophages from CLL patients.
Oncogene
; 40(6): 1203, 2021 Feb.
Article
in En
| MEDLINE
| ID: mdl-33353962
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Oncogene
Journal subject:
BIOLOGIA MOLECULAR
/
NEOPLASIAS
Year:
2021
Document type:
Article
Affiliation country:
Australia